- Home
- NESR vs ABUS Comparison
NESR vs ABUS Comparison
Compare NESR & ABUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NESR
- ABUS
- Stock Information
- Founded
- NESR 2017
- ABUS N/A
- Country
- NESR United States
- ABUS United States
- Employees
- NESR N/A
- ABUS N/A
- Industry
- NESR
- ABUS Biotechnology: Pharmaceutical Preparations
- Sector
- NESR
- ABUS Health Care
- Exchange
- NESR NYSE
- ABUS Nasdaq
- Market Cap
- NESR 810.3M
- ABUS 697.3M
- IPO Year
- NESR N/A
- ABUS N/A
- Fundamental
- Price
- NESR $8.24
- ABUS $3.21
- Analyst Decision
- NESR Strong Buy
- ABUS Strong Buy
- Analyst Count
- NESR 2
- ABUS 4
- Target Price
- NESR $14.00
- ABUS $5.50
- AVG Volume (30 Days)
- NESR 149.4K
- ABUS 903.4K
- Earning Date
- NESR 11-19-2024
- ABUS 11-06-2024
- Dividend Yield
- NESR N/A
- ABUS N/A
- EPS Growth
- NESR N/A
- ABUS N/A
- EPS
- NESR 0.54
- ABUS N/A
- Revenue
- NESR $1,265,542,000.00
- ABUS $6,742,000.00
- Revenue This Year
- NESR $13.71
- ABUS N/A
- Revenue Next Year
- NESR $7.75
- ABUS N/A
- P/E Ratio
- NESR $15.24
- ABUS N/A
- Revenue Growth
- NESR 39.14
- ABUS N/A
- 52 Week Low
- NESR $7.68
- ABUS $2.21
- 52 Week High
- NESR $9.89
- ABUS $4.72
- Technical
- Relative Strength Index (RSI)
- NESR N/A
- ABUS 33.77
- Support Level
- NESR N/A
- ABUS $3.13
- Resistance Level
- NESR N/A
- ABUS $3.61
- Average True Range (ATR)
- NESR 0.00
- ABUS 0.17
- MACD
- NESR 0.00
- ABUS -0.03
- Stochastic Oscillator
- NESR 0.00
- ABUS 12.12
About NESR NATIONAL ENERGY SVCS REUNITED CORP
National Energy Services Reunited Corp is a British Virgin Islands-based company engaged in providing products and services to the oil and gas industry in the Middle East and North Africa and the Asia Pacific regions. The company has two reportable segments: Production Services including coil tubing, stimulation, and pumping, nitrogen services, completions, pipelines, cementing, laboratory services and filtration services; and Drilling and Evaluation Services including drilling and workover rigs, rig services, services, and well-testing services among others. Revenues are majorly derived from production services of an oil or natural gas well.
About ABUS Arbutus Biopharma Corporation
Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. The company is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology.